Activating peripheral arterial disease patients to reduce cholesterol: A randomized trial

Mary M. McDermott, George Reed, Philip Greenland, Kathy M. Mazor, Sherry Pagoto, Judith K. Ockene, Rex Graff, Philip A. Merriam, Kathy Leung, Larry Manheim, Melina R. Kibbe, Barbara Olendzki, William H. Pearce, Ira S. Ockene

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Background: Peripheral arterial disease patients are less likely than other high-risk patients to achieve ideal low-density lipoprotein (LDL) cholesterol levels. This randomized controlled trial assessed whether a telephone counseling intervention, designed to help peripheral arterial disease patients request more intensive cholesterol-lowering therapy from their physician, achieved lower LDL cholesterol levels than 2 control conditions. Methods: There were 355 peripheral arterial disease participants with baseline LDL cholesterol <70 mg/dL enrolled. The primary outcome was change in LDL cholesterol level at 12-month follow-up. There were 3 parallel arms: telephone counseling intervention, attention control condition, and usual care. The intervention consisted of patient-centered counseling, delivered every 6 weeks, encouraging participants to request increases in cholesterol-lowering therapy from their physician. The attention control condition consisted of telephone calls every 6 weeks providing information only. The usual care condition participated in baseline and follow-up testing. Results: At 12-month follow-up, participants in the intervention improved their LDL cholesterol level, compared with those in attention control (-18.4 mg/dL vs -6.8 mg/dL, P = .010) but not compared with those in usual care (-18.4 mg/dL vs -11.1 mg/dL, P = .208). Intervention participants were more likely to start a cholesterol-lowering medication or increase their cholesterol-lowering medication dose than those in the attention control (54% vs 18%, P = .001) and usual care (54% vs 31%, P <.001) conditions. Conclusion: Telephone counseling that helped peripheral arterial disease patients request more intensive cholesterol-lowering therapy from their physician achieved greater LDL cholesterol decreases than an attention control arm that provided health information alone.

Original languageEnglish (US)
Pages (from-to)557-565
Number of pages9
JournalAmerican Journal of Medicine
Volume124
Issue number6
DOIs
StatePublished - Jun 1 2011

    Fingerprint

Keywords

  • Intermittent claudication
  • Peripheral arterial disease
  • Secondary prevention

ASJC Scopus subject areas

  • Medicine(all)

Cite this

McDermott, M. M., Reed, G., Greenland, P., Mazor, K. M., Pagoto, S., Ockene, J. K., Graff, R., Merriam, P. A., Leung, K., Manheim, L., Kibbe, M. R., Olendzki, B., Pearce, W. H., & Ockene, I. S. (2011). Activating peripheral arterial disease patients to reduce cholesterol: A randomized trial. American Journal of Medicine, 124(6), 557-565. https://doi.org/10.1016/j.amjmed.2010.11.032